Contemporary Drug Development in Heart Failure-Reference-Cited by-同舟云学术

Contemporary Drug Development in Heart Failure

Published:2015-07 Issue:4 Volume:8 Page:826-831
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ: Heart Failure

Author:

Vaduganathan Muthiah¹,Butler Javed¹,Pitt Bertram¹,Gheorghiade Mihai¹

Affiliation:

1. From the Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (M.V.); Division of Cardiology, Stony Brook University, NY (J.B.); University of Michigan School of Medicine, Ann Arbor (B.P.); and Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, IL (M.G.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.115.002271

Reference37 articles.

1. National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008

2. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.;Ambrosy AP;Am Heart J,2013

3. Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model

4. Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure

5. Acute Heart Failure Syndromes and Coronary Perfusion

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and risk factors of hypotension-related adverse events among Japanese patients with heart failure receiving sacubitril/valsartan or enalapril: Results from the PARALLEL-HF study;Journal of Cardiology;2024-09

2. Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Heart Failure According to Baseline Systolic Blood Pressure　― Results From a Subgroup Analysis of the PARALLEL-HF Study ―;Circulation Journal;2023-12-25

3. Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis;Heart and Vessels;2023-09-11

4. Renin–Angiotensin–Aldosterone System as an Old New Target in Heart Failure Therapy;The Renin Angiotensin System in Cardiovascular Disease;2023

5. The Design of Multi-target Drugs to Treat Cardiovascular Diseases: Two (or more) Birds on One Stone;Current Topics in Medicinal Chemistry;2022-02